Grenco Medical is the medical device division of Grenco Science, creators of the pioneering G Pen vaporization technology. With nearly 15 years of engineering and manufacturing expertise in cannabinoid delivery systems, Grenco Medical represents the next evolution in precision-based, certified medical-grade vaporization solutions for global healthcare markets.

Our mission is to elevate the standard of care in cannabinoid-based therapies by developing safe, effective, and rigorously tested inhalation devices for patients enrolled in legal medical cannabis programs. Grenco Medical devices are engineered to meet the exacting requirements of the international medical device community—combining clinical reliability with ease of use for patients and providers alike.

All Grenco Medical products are developed and manufactured in ISO 13485-certified and GMP-compliant facilities, purpose-built for the production of Class I and Class II medical devices. Our devices undergo extensive third-party testing, including biocompatibility assessments, thermal profiling, emissions analysis, and electrical safety validation to ensure full regulatory compliance and patient safety.

Our inaugural product, the Grenco Medical Elite II Vaporiser, is based on the industry-trusted G Pen Elite II platform and re-engineered within our medical-grade infrastructure. It has successfully passed all testing required for international certification as a medical device for the vaporization of dry medical cannabis flower.

With certifications secured in key global jurisdictions including Health Canada, New Zealand Health and the Therapeutic Goods Administration of Australia (pending) and an expanding portfolio of devices in development, Grenco Medical is at the forefront of innovation in cannabinoid delivery—empowering physicians and patients with clean, consistent, and clinically dependable vaporization solutions.